SEC 13F Intelligence

Versant Venture Management, LLC / AKRO

Versant Venture Management, LLC’s Akero Therapeutics Inc Com Position

Does Versant Venture Management, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 617.7K shares worth $9M in Q1 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$9M
Q1 2022
Shares
617.7K
% of Portfolio
+8.75%
Quarters Held
9
position exited

Position History AKRO

Reported value by quarter
Q1 ’20: $58.0BQ1 ’20Q2 ’20: $52.7BQ3 ’20: $24MQ3 ’20Q4 ’20: $20MQ1 ’21: $18MQ1 ’21Q2 ’21: $15MQ3 ’21: $14MQ3 ’21Q4 ’21: $13MQ1 ’22: $9MQ1 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2022617.7K$9M+8.75%
Q4 2021617.7K$13M+6.99%
Q3 2021617.7K$14M+5.72%
Q2 2021617.7K$15M+5.08%
Q1 2021617.7K$18M+3.49%
Q4 2020777.7K$20M+2.08%
Q3 2020777.7K$24M+4.38%
Q2 20202.12M$52.7B+7.57%
Q1 20202.74M$58.0B+15.91%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Versant Venture Management, LLC’s full portfolio or all institutional holders of AKRO.